Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melina Verso

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
The Lancet. Oncology|September 4, 2009
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind studyGiancarlo Agnelli, Gualberto Gussoni, Carlo Bianchini, et al.
The New England Journal of Medicine|March 31, 2020
Apixaban for the Treatment of Venous Thromboembolism Associated with CancerGiancarlo Agnelli, Cecilia Becattini, Guy Meyer, et al.
Thrombosis and Haemostasis|August 14, 2018
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio StudyGiancarlo Agnelli, Cecilia Becattini, Rupert Bauersachs, et al.
Thrombosis and Haemostasis|April 5, 2022
Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical TrialAlberto Carmona-Bayonas, Melina Verso, Manuel Sánchez Cánovas, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
The Lancet. Oncology|September 4, 2009
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind studyGiancarlo Agnelli, Gualberto Gussoni, Carlo Bianchini, et al.
The New England Journal of Medicine|March 31, 2020
Apixaban for the Treatment of Venous Thromboembolism Associated with CancerGiancarlo Agnelli, Cecilia Becattini, Guy Meyer, et al.
Thrombosis and Haemostasis|August 14, 2018
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio StudyGiancarlo Agnelli, Cecilia Becattini, Rupert Bauersachs, et al.
Thrombosis and Haemostasis|April 5, 2022
Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical TrialAlberto Carmona-Bayonas, Melina Verso, Manuel Sánchez Cánovas, et al.
Pageof 5